Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension.
about
Clinical use of alprostadil topical cream in patients with erectile dysfunction: a reviewSafety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertensionNew insights into male (in)fertility: the importance of NOAnti-platelet therapy: phosphodiesterase inhibitors.Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experienceAdulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A ReviewStimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissueRole of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts.Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.Phosphodiesterase 8a supports HIV-1 replication in macrophages at the level of reverse transcriptionThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesUnderstanding and Managing Erectile Dysfunction in Patients Treated for CancerDrug-related problems in patients with erectile dysfunctions and multiple comorbidities.Vardenafil orodispersible tablet.Antihypertensive Drugs and Male Sexual Dysfunction: A Review of Adult Hypertension Guideline Recommendations.Hemodynamic effect of avanafil and glyceryl trinitrate coadministration.Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension.Phosphodiesterase type 5 and cancers: progress and challenges.Reproductive Health of Men with Spinal Cord Injury.Acute effects of vardenafil on pulmonary artery responsiveness in pulmonary hypertension
P2860
Q26740510-FD926903-ADAC-41E0-84FE-F4946FF5C9CDQ26771505-5E192B76-E278-433A-8104-D973E836203EQ26827970-9363D305-AA27-45CB-A0C8-28634124EDEAQ27687228-C09830A0-FE4A-41D2-A39E-1AA1ADBCA5E9Q28071503-75074EB0-F138-479A-BF3F-086E2E191E2DQ29395258-81C2947D-03DA-4FB5-9B8D-902586531186Q30316523-D4133731-5466-45EF-A07C-07B3F8D6B0F0Q30575578-623AEA71-1EC4-4901-9A2D-DC18BC3B8DCFQ30583012-9BA94F24-7D14-40FE-AE4B-9E705463ABFAQ34309051-7AF19F2F-4422-4FE5-AC49-7EECDCE117BEQ35156618-68F6CA45-D041-412C-997C-682CD30DAED1Q37240940-F495CFAB-1B79-4469-9EDC-263AE420E9FEQ37742049-6276A452-5FD7-4CA0-8373-44C448A525A4Q37970759-03964921-1A9C-4D46-8195-D2854B3B577BQ38602936-274ED464-32EB-40BC-9605-E16BFFDDD4BDQ41859015-1F62AC6F-BF8A-4D02-967E-26E4AB9F4C3CQ45895088-6707743C-4518-4B87-B7B9-7FDC709E074EQ47171803-5ED9C301-DC46-4AEE-8B01-3EE1322C3F15Q49330233-9BF34E6F-A912-4499-9B04-3A770F52F18CQ58915012-1B25106D-134A-4D86-A3ED-87E02F99D565
P2860
Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug interactions with phospho ...... ion or pulmonary hypertension.
@en
Drug interactions with phospho ...... ion or pulmonary hypertension.
@nl
type
label
Drug interactions with phospho ...... ion or pulmonary hypertension.
@en
Drug interactions with phospho ...... ion or pulmonary hypertension.
@nl
prefLabel
Drug interactions with phospho ...... ion or pulmonary hypertension.
@en
Drug interactions with phospho ...... ion or pulmonary hypertension.
@nl
P1433
P1476
Drug interactions with phospho ...... ion or pulmonary hypertension.
@en
P2093
Bryan G Schwartz
Robert A Kloner
P356
10.1161/CIRCULATIONAHA.110.944603
P407
P577
2010-07-01T00:00:00Z